Leukemia Overview and Hematopoiesis
14 Questions
1 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the typical prognosis for a patient with acute lymphoblastic leukemia (ALL) exhibiting hyperdiploidy?

  • Good prognosis (correct)
  • Prognosis cannot be determined with this information
  • Prognosis is not affected by hyperdiploidy
  • Poor prognosis
  • What is the chromosomal translocation associated with a poorer prognosis in adult patients with ALL?

  • t(11;19)
  • t(9;22) (correct)
  • t(11;14)
  • t(15;17)
  • t(8;21)
  • What is the approximate percentage of adult ALL patients that have the Philadelphia chromosome?

  • 35-45%
  • 20-30% (correct)
  • 5-10%
  • 15-25%
  • What diagnostic procedure is indicated in cases of suspected central nervous system (CNS) involvement in ALL?

    <p>Lumbar puncture (A)</p> Signup and view all the answers

    In what percentage of children with ALL is the Philadelphia chromosome typically found?

    <p>5-10% (A)</p> Signup and view all the answers

    Which of the following is a clinical feature of bone marrow failure?

    <p>Decreased red blood cell count (C)</p> Signup and view all the answers

    What is a common symptom of anemia caused by bone marrow failure?

    <p>Shortness of breath (B)</p> Signup and view all the answers

    Which of the following is a characteristic feature of neutropenia associated with bone marrow failure?

    <p>Increased risk of infection (B)</p> Signup and view all the answers

    Which of the following symptoms is commonly observed in patients with bone marrow failure due to neutropenia?

    <p>Fever (D)</p> Signup and view all the answers

    Which of the following markers are typically found on the cell membrane of B-lymphoblast cells?

    <p>CD19, CD20, CD22, CD10 (A)</p> Signup and view all the answers

    T-lymphoblasts are characterized by the presence of which of the following cell surface markers?

    <p>CD2, CD3, CD5, CD7 (C)</p> Signup and view all the answers

    What type of analysis can provide valuable information about the prognosis and potential treatment options for patients with hematologic malignancies?

    <p>Cytogenetic analysis (C)</p> Signup and view all the answers

    In the context of hematologic malignancies, what is the significance of detecting the presence of CD10 on the cell surface?

    <p>It is commonly associated with B-cell precursor acute lymphoblastic leukemia. (A)</p> Signup and view all the answers

    Which of the following statements is true regarding the use of cell surface markers in hematologic malignancies?

    <p>They can assist in diagnosis and classification of various hematological malignancies. (C)</p> Signup and view all the answers

    Study Notes

    Leukemia-1

    • Leukemia is a malignant proliferation of hematopoietic cells in the bone marrow, followed by blood and soft tissue infiltration.
    • Symptoms arise from bone marrow failure (e.g., anemia, neutropenia, thrombocytopenia) and organ infiltration (e.g., liver, spleen, lymph nodes, meninges, brain, skin, or testes).
    • Learning objectives include defining leukemia, describing its types, identifying predisposing factors, and describing acute lymphoblastic and acute myeloblastic leukemias.

    Maturation of Hematopoietic Cells

    • The presentation visually depicts the maturation process of blood cells.
    • It showcases different stages of development, highlighting crucial cells like myeloblasts, promyelocytes, and myelocytes, culminating in mature blood cells.

    Definition

    • Leukemia is characterized by uncontrolled proliferation of blast cells, primarily in the bone marrow, leading to infiltration of peripheral blood and soft tissues.
    • Blast cells must constitute more than 20% of bone marrow cells for an acute leukemia diagnosis.

    Classification

    • Acute leukemias are categorized based on the type of blast cells (lymphoblasts or myeloblasts).
    • Acute lymphoblastic leukemia (ALL) is often associated with childhood and L1-L3 classifications.
    • Acute myeloblastic leukemia (AML) is more frequently observed in adulthood and can range from M0 to M7.
    • Chronic leukemias include chronic lymphocytic leukemia (CLL) and chronic myelocytic leukemia (CML).

    Predisposing Factors

    • Congenital disorders like Down syndrome and Klinefelter syndrome can be risk factors.
    • Immunodeficiency syndromes can elevate the risk.
    • Exposure to ionizing radiation (e.g., nuclear fallout, therapeutic irradiation, diagnostic X-rays) is a significant factor.
    • Chemical agents (e.g., alkylating agents in chemotherapy, benzene exposure) can increase risk.
    • Smoking is a potential risk factor.
    • Certain viruses (e.g., HTLV-1, Herpes viruses, EBV) are linked to leukemia development.

    Acute Lymphoblastic Leukemia (ALL)

    • ALL is characterized by the uncontrolled proliferation of B- or T-lymphoblasts (lymphoid precursor cells).
    • ALL is the most prevalent malignant disease in children.
    • Peak incidence occurs between ages 2 and 5.
    • About 85% of ALL cases are of the B-type, predominately affecting children. 15% are T-cell type, common in adolescents.
    • Clinical characteristics include bone marrow failure, leading to symptoms like anemia, neutropenia, and thrombocytopenia, and tissue infiltration (e.g., enlarged lymph nodes, spleen, or liver).
    • Investigations involve a complete blood count (CBC) (leukocytosis, anemia, thrombocytopenia), peripheral blood smear (leukocytosis and lymphoblasts), bone marrow examination (hypercellular bone marrow with over 20% lymphoblasts), cytochemistry (TdT - positive result), immunophenotyping, and cytogenetic analysis. Results from these tests help confirm the diagnosis and determine prognosis.

    Acute Myeloblastic Leukemia (AML)

    • AML arises from the malignant proliferation of myeloid precursor cells (myeloblasts).
    • The disease affects people of all ages, with incidence peaks post-60 years.
    • AML categorization is based on the FAB system (M0 to M7), distinguishing it by maturation degree and lineage of the leukemic blast cells.
    • Characteristic clinical features involve bone marrow dysfunction (anemia, neutropenia, thrombocytopenia) and tissue infiltration.
    • Diagnostics utilize CBC (leukocytosis, anemia, thrombocytopenia), peripheral smear (leukocytosis and myeloblasts), bone marrow aspiration to examine hypercellular bone marrow (presence of over 20% myeloblasts), cytochemistry (MPO - positive) and immunophenotyping (myeloid markers like CD13 and CD33), cytogenetic analyses (e.g., t(8;21), inv(16), t(15;17)) for additional characterization.

    Investigation Points

    • Complete Blood Count (CBC): WBCs are commonly leucocytic which may reach ≥100,000/mm³, RBCs show anemia and platelets display thrombocytopenia.
    • Peripheral Smear: Peripheral blood smear reveals leukocytosis with lymphocytes or myelocytes, and/or myeloblasts.
    • Bone Marrow: Hypercellular bone marrow with >20% of myeloblasts/lymphoblasts is examined.
    • Cytochemistry: Additional testing (examples include MPO/TdT) is done.
    • Immunophenotyping: This uses flow cytometry to detect markers on the blast cell surface.
    • Cytogenetic analysis: This assesses and studies the chromosomal composition of cells.
    • Other Investigations: Tests may include lumbar puncture for CNS involvement and/or testicular biopsy for relapse.

    Prognosis

    • Aggressive chemotherapy commonly results in remission in approximately 95% of children with ALL, with 75-85% achieving long-term cures.
    • Factors linked to a less favorable prognosis include age (<2 or >10 years), CNS involvement, high WBC counts and specific chromosomal abnormalities (e.g., Philadelphia chromosome t(9;22)).
    • Favorable prognosis markers in ALL include age (2–10 years), low white blood cell count (< 50,000/mm3), hyperploidy, and t(12;21).

    Case Studies

    • Case studies are presented to illustrate scenarios involving leukemia diagnosis and associated translocations.

    References

    • The provided references (e.g., Robbins Basic Pathology) and AMBOSS Link offer further in-depth details and resources.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Leukemia-I (Acute Leukemia) PDF

    Description

    This quiz covers key concepts related to leukemia, including its definitions, types, symptoms, and pathophysiology. Additionally, it explores the maturation process of hematopoietic cells, detailing the stages from myeloblasts to mature blood cells. Test your understanding of these critical topics in hematology.

    More Like This

    Use Quizgecko on...
    Browser
    Browser